Introduction
Follicular lymphoma (FL) is a slow-growing form of non-Hodgkin lymphoma that develops in B lymphocytes, a type of white blood cell involved in the immune system. Although many patients respond to initial treatment, the disease may return or become resistant to therapy, requiring additional treatment options.
Lunsumio is an intravenous cancer immunotherapy approved for adults with relapsed or refractory follicular lymphoma after two or more prior lines of systemic therapy. Unlike traditional chemotherapy, Lunsumio works by directing the body’s own immune system to identify and destroy lymphoma cells.
Because Lunsumio is a specialty biologic medication administered through IV infusion, treatment costs can be high. Many people searching for a Lunsumio patient assistance program are looking for ways to reduce their prescription expenses.
Patient assistance programs offer prescription assistance to qualified patients. Prescription Hope provides application support and services, as well as ongoing administrative management.
What Is the Lunsumio Patient Assistance Program?
Understanding Lunsumio Prescription Assistance
Due to the high cost of specialty medications, patients often search for affordable Lunsumio or Follicular lymphoma medication assistance.
Manufacturers understand that patients searching for medications like these need financial relief for their medication costs. Therefore, many manufacturers offer patient assistance programs to help qualified patients.
These programs provide affordable medications to help qualified patients. However, many of these programs are difficult to navigate, leaving patients frustrated when applying on their own
How Expert Advocates Help Make Lunsumio More Affordable
Personalized Medication Assistance
Patients who are seeking trusted prescription assistance specialists need to look no further than Prescription Hope. Our patient support services take care of the application process for patient assistance programs, from start to finish. If you are seeking Lunsumio enrollment assistance, our team of specialists is here for you.
At Prescription Hope, our dedicated team manages form completion, document and signature collection, coordination with healthcare providers and manufacturers, and all the red tape that comes with applying for patient assistance programs.
Ongoing Patient Support
At Prescription Hope, our services don’t end once the application for assistance has been submitted; we also offer long-term medication assistance. Our team manages administrative tasks such as form and document updates, issue resolution, program monitoring, yearly renewals, and even refill scheduling.
Lunsumio Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Follicular Lymphoma Treatment Costs
While follicular lymphoma medications can be extremely expensive, Lunsumio cost assistance through Prescription Hope can make all the difference.
For $70.00 per month, per medication, patients get access to specialty follicular lymphoma medication assistance without any hidden fees or charges, variable pricing systems, or medication costs.
Lunsumio Patient Assistance Eligibility
General Eligibility Requirements
While determining specific Lunsumio patient assistance qualifications is best done by enrolling with Prescription Hope, it’s beneficial to understand general prescription assistance requirements.
They include:
Income: Each program maintains its own income threshold.
Insurance: Each program maintains its own requirement regarding insurance coverage status.
Prescription: All qualified patients must have a valid prescription for their brand-name medication they wish to apply for.
U.S. residency: All qualified patients must have legal U.S. residency.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Are you ready to enroll in Lunsumio assistance? Then enroll with Prescription Hope today. Enrollment with Prescription Hope takes only 6 steps:
- Submit Information: Our online form can be completed in just a few minutes.
- Advocate Contact: A patient advocate will contact you in 1-2 business days.
- Document Collection: Following a quick prequalification, our team will collect needed documents.
- Provider Coordination: We connect with your healthcare provider to secure vital signatures.
- Program Submission: Our team completes your application packet, submits it, and continues to follow up with the manufacturer.
- Medication Delivery: Once approved, qualified patients can typically expect to receive their medication within 2 weeks, though shipping times may vary. All medication shipments come directly from the manufacturer to your home or doctor’s office.
Understanding Lunsumio
How Lunsumio Works
Lunsumio is a bispecific monoclonal antibody that binds to two different proteins:
- CD20, found on B-cell lymphoma cells
- CD3, found on T cells (immune cells)
By simultaneously binding CD20 on malignant B cells and CD3 on T cells, Lunsumio redirects T cells to recognize and destroy lymphoma cells.
Unlike traditional chemotherapy, Lunsumio works by directing the patient’s own immune system to attack cancer cells.
What Conditions Does Lunsumio Treat?
Lunsumio is FDA-approved for the treatment of adults with relapsed or refractory follicular lymphoma (FL), Grade 1, 2, or 3A, after two or more prior lines of systemic therapy.
Follicular lymphoma is a slow-growing type of non-Hodgkin lymphoma that begins in B lymphocytes (B cells). This medication is intended for patients whose lymphoma has returned or has not responded after multiple previous treatments.
This medication initially received accelerated approval in 2022, and in 2024 the FDA converted the indication to traditional approval based on confirmatory clinical trial results.
Benefits of Treatment
Lunsumio may help:
- Shrink or eliminate lymphoma tumors
- Produce durable responses in many patients with relapsed or refractory disease
- Activate the immune system to target lymphoma cells
- Provide a chemotherapy-free treatment option
- Offer a fixed-duration treatment schedule for many patients
- Improve disease control in heavily pretreated follicular lymphoma
Individual responses vary, and treatment effectiveness depends on the patient’s disease characteristics and overall health.
Important Safety Information and Side Effects
Lunsumio carries an FDA Boxed Warning for Cytokine Release Syndrome (CRS).
This medication can cause cytokine release syndrome, which may be serious, life-threatening, or fatal.
Symptoms may include:
- Fever
- Chills
- Low blood pressure
- Difficulty breathing
- Rapid heartbeat
- Severe fatigue
- Confusion
To reduce this risk, treatment begins with a step-up dosing schedule, and patients receive premedications before early doses. Healthcare providers monitor patients closely during and after infusions, particularly during the first treatment cycle.
Serious or life-threatening neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome (ICANS), has occurred.
Symptoms may include:
- Confusion
- Tremor
- Difficulty speaking
- Seizures
- Reduced level of consciousness
Patients should immediately report any new or worsening neurologic symptoms.
The most commonly reported side effects include:
- Cytokine release syndrome (CRS)
- Fatigue
- Rash
- Fever
- Headache
- Musculoskeletal pain
- Nausea
- Diarrhea
- Infusion-related reactions
Common laboratory abnormalities include:
- Decreased neutrophil counts (neutropenia)
- Decreased lymphocyte counts
- Decreased phosphate levels
- Increased liver enzyme levels
Patients should discuss the following additional risks with their healthcare provider:
- Serious bacterial, viral, fungal, and opportunistic infections
- Tumor flare
- Tumor lysis syndrome
- Embryo-fetal toxicity
Lunsumio may harm an unborn baby. Females of reproductive potential should use effective contraception during treatment and for 3 months after the final dose. Patients should notify their healthcare provider immediately if pregnancy occurs during treatment.
Breastfeeding is not recommended during treatment and for 3 months after the final dose.
No formal clinical drug-drug interaction studies have been conducted with this medication. Patients should still inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before starting treatment.
This medication is administered by intravenous (IV) infusion by a healthcare professional. Treatment begins with a step-up dosing schedule during the first treatment cycle to reduce the risk of cytokine release syndrome. Premedications are given before early doses, and maintenance infusions are generally administered every 21 days after the initial step-up period. Treatment is typically given for a fixed duration of eight cycles, with some patients who achieve a partial response after eight cycles receiving up to 17 cycles according to the prescribing information. Patients are monitored closely during and after infusions, particularly during the initial treatment cycles.
Access to Multiple Medications
Support Beyond Lunsumio
Are you looking for specialty biologic support as well as other specialty medication access? Prescription Hope routinely helps qualified patients access multiple medication assistance programs at once. Whether one or many, our team provides all services for a simple $70.00 per month, per medication.
Why Choose Prescription Hope
Patient-Focused Medication Support
For two decades, patients have trusted Prescription Hope to help them receive patient-centered assistance and support that provides them with prescription affordability support. Our Florida-based medication access specialists can provide Lunsumio assistance services through Prescription Hope.
Simplified Access to Prescription Medications
At Prescription Hope, our patient assistance services and medication access support help provide qualified patients with the support they need to access affordable Lunsumio by lowering the costs of medication and providing peace of mind when it comes to prescription medication prices.
Ongoing Prescription Assistance
Not only does Prescription Hope help with follicular lymphoma treatment support, but we also provide long-term medication support. Our dedicated team of patient advocates takes care of form and document updates, issue resolution, yearly renewals, program monitoring, and even refill scheduling.
If you are looking for access to affordable brand-name medications like Lunsumio, then enroll with Prescription Hope today!